Vincent E. Aurentz
Net Worth

Last updated:

What is Vincent E. Aurentz net worth?

The estimated net worth of Mr. Vincent E. Aurentz is at least $12,452,050 as of 16 Feb 2021. He owns shares worth $2,699,730 as insider, has earned $5,595,400 from insider trading and has received compensation worth at least $4,156,920 in Arena Pharmaceuticals, Inc..

What is the salary of Vincent E. Aurentz?

Mr. Vincent E. Aurentz salary is $692,820 per year as Executive Vice President & Chief Bus. Officer in Arena Pharmaceuticals, Inc..

How old is Vincent E. Aurentz?

Mr. Vincent E. Aurentz is 57 years old, born in 1968.

What stocks does Vincent E. Aurentz currently own?

As insider, Mr. Vincent E. Aurentz owns shares in one company:

Company Title Shares Price per share Total value
Arena Pharmaceuticals, Inc. (ARNA) Executive Vice President & Chief Bus. Officer 27,000 $99.99 $2,699,730

What does Arena Pharmaceuticals, Inc. do?

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

ARNA logo
ARNA
Arena Pharmaceuticals, Inc.
$99.99

Vincent E. Aurentz insider trading

Arena Pharmaceuticals, Inc.

Mr. Vincent E. Aurentz has made 4 insider trades between 2019-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 65,000 units of ARNA stock on 9 Sep 2019. As of 16 Feb 2021 he still owns at least 27,000 units of ARNA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 2,524 $17.8 $44,927
Sale
Common Stock 2,524 $85 $214,540
Option
Employee Stock Option (right to buy) 2,524 N/A N/A
Option
Employee Stock Option (right to buy) 2,524 $25.1 $63,352
Option
Performance Restricted Stock Unit 18,000 N/A N/A
Option
Common Stock 18,000 N/A N/A
Option
Performance Restricted Stock Unit 9,000 N/A N/A
Option
Common Stock 9,000 N/A N/A
Option
Common Stock 25,000 $23.27 $581,675
Sale
Common Stock 25,000 $65 $1,625,025
Option
Employee Stock Option (right to buy) 25,000 $23.27 $581,675
Sale
Common Stock 9,000 $50 $450,000
Option
Common Stock 9,000 N/A N/A
Option
Performance Restricted Stock Unit 9,000 N/A N/A
Option
Employee Stock Option (right to buy) 65,000 $22.43 $1,458,145
Option
Common Stock 65,000 $22.43 $1,458,145
Sale
Common Stock 65,000 $50.86 $3,305,835

Arena Pharmaceuticals key executives

Arena Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: